Literature DB >> 23442231

Genetically obese mice do not show increased gut permeability or faecal bile acid hydrophobicity.

Lotta K Stenman1, Reetta Holma, Helena Gylling, Riitta Korpela.   

Abstract

Gut barrier dysfunction may lead to metabolic endotoxaemia and low-grade inflammation. Recent publications have demonstrated gut barrier dysfunction in obesity induced by a diet high in fat, and a pathogenetic role for luminal bile acids has been proposed. We aimed to investigate whether genetically obese mice develop increased gut permeability and alterations in luminal bile acids on a diet with a regular fat content. We used seven obese male ob/ob mice of C57BL/6J background and ten male wild-type (WT) mice of the same strain. Faeces were collected for bile acid analysis. Intestinal permeability was measured in an Ussing chamber upon euthanasia, using 4 kDa fluorescein isothiocyanate dextran, as per mille (‰, 1/1000) of translocated dextran. We analysed the liver expression of lipopolysaccharide-binding protein (LBP), as well as serum LBP (ELISA). Intestinal permeability was not affected by genetic obesity (jejunum: 0·234 (sem 0·04) ‰ for obese v. 0·225 (sem 0·03) ‰ for WT, P= 0·93; colon: 0·222 (sem 0·06) ‰ for obese v. 0·184 (sem 0·03) ‰ for WT, P= 0·86), nor was liver LBP expression (relative expression: 0·55 (sem 0·08) for obese v. 0·55 (sem 0·13) for WT, P= 0·70). Serum LBP was 2·5-fold higher in obese than in WT mice (P= 0·001). Obese mice had increased daily excretion of total bile acids, but their faecal bile acid hydrophobicity was unchanged. In conclusion, genetic obesity did not impair gut barrier function in mice on a regular chow diet, nor was faecal bile acid hydrophobicity affected.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23442231     DOI: 10.1017/S000711451300024X

Source DB:  PubMed          Journal:  Br J Nutr        ISSN: 0007-1145            Impact factor:   3.718


  11 in total

1.  Epithelial CaSR deficiency alters intestinal integrity and promotes proinflammatory immune responses.

Authors:  Sam X Cheng; Yaíma L Lightfoot; Tao Yang; Mojgan Zadeh; Lieqi Tang; Bikash Sahay; Gary P Wang; Jennifer L Owen; Mansour Mohamadzadeh
Journal:  FEBS Lett       Date:  2014-05-17       Impact factor: 4.124

2.  Tauroursodeoxycholic acid inhibits intestinal inflammation and barrier disruption in mice with non-alcoholic fatty liver disease.

Authors:  Weijun Wang; Jinfang Zhao; Wenfang Gui; Dan Sun; Haijiang Dai; Li Xiao; Huikuan Chu; Fan Du; Qingjing Zhu; Bernd Schnabl; Kai Huang; Ling Yang; Xiaohua Hou
Journal:  Br J Pharmacol       Date:  2018-01-03       Impact factor: 8.739

3.  Enhanced gastrointestinal passive paracellular permeability contributes to the obesity-associated hyperoxaluria.

Authors:  Mohamed Bashir; Jon Meddings; Altayeb Alshaikh; Daniel Jung; Kim Le; Ruhul Amin; Sireesha Ratakonda; Sapna Sharma; Ignacio Granja; Mustafa Satti; John Asplin; Hatim Hassan
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-10-11       Impact factor: 4.052

4.  Impact of Dietary Lipids on Colonic Function and Microbiota: An Experimental Approach Involving Orlistat-Induced Fat Malabsorption in Human Volunteers.

Authors:  Pamela Morales; Sayaka Fujio; Paola Navarrete; Juan A Ugalde; Fabien Magne; Catalina Carrasco-Pozo; Karina Tralma; MariaPaz Quezada; Carmen Hurtado; Natalia Covarrubias; Jerusa Brignardello; Daniela Henriquez; Martin Gotteland
Journal:  Clin Transl Gastroenterol       Date:  2016-04-07       Impact factor: 4.488

Review 5.  Role of Obesity, Mesenteric Adipose Tissue, and Adipokines in Inflammatory Bowel Diseases.

Authors:  Jan Bilski; Agnieszka Mazur-Bialy; Dagmara Wojcik; Marcin Surmiak; Marcin Magierowski; Zbigniew Sliwowski; Robert Pajdo; Slawomir Kwiecien; Aleksandra Danielak; Agata Ptak-Belowska; Thomas Brzozowski
Journal:  Biomolecules       Date:  2019-11-26

6.  Regulation of Intestinal Inflammation by Dietary Fats.

Authors:  Abigail R Basson; Christy Chen; Filip Sagl; Ashley Trotter; Ilya Bederman; Adrian Gomez-Nguyen; Mark S Sundrud; Sanja Ilic; Fabio Cominelli; Alex Rodriguez-Palacios
Journal:  Front Immunol       Date:  2021-02-02       Impact factor: 7.561

7.  Lactobacillus casei Shirota Supplementation Does Not Restore Gut Microbiota Composition and Gut Barrier in Metabolic Syndrome: A Randomized Pilot Study.

Authors:  Vanessa Stadlbauer; Bettina Leber; Sandra Lemesch; Slave Trajanoski; Mina Bashir; Angela Horvath; Monika Tawdrous; Tatjana Stojakovic; Günter Fauler; Peter Fickert; Christoph Högenauer; Ingeborg Klymiuk; Philipp Stiegler; Manfred Lamprecht; Thomas R Pieber; Norbert J Tripolt; Harald Sourij
Journal:  PLoS One       Date:  2015-10-28       Impact factor: 3.240

8.  High fat diet accelerates pathogenesis of murine Crohn's disease-like ileitis independently of obesity.

Authors:  Lisa Gruber; Sigrid Kisling; Pia Lichti; François-Pierre Martin; Stephanie May; Martin Klingenspor; Martina Lichtenegger; Michael Rychlik; Dirk Haller
Journal:  PLoS One       Date:  2013-08-16       Impact factor: 3.240

9.  Decreased basal chloride secretion and altered cystic fibrosis transmembrane conductance regulatory protein, Villin, GLUT5 protein expression in jejunum from leptin-deficient mice.

Authors:  Lana Leung; Jonathan Kang; Esa Rayyan; Ashesh Bhakta; Brennan Barrett; David Larsen; Ryan Jelinek; Justin Willey; Scott Cochran; Tom L Broderick; Layla Al-Nakkash
Journal:  Diabetes Metab Syndr Obes       Date:  2014-07-21       Impact factor: 3.168

10.  Maternal High Fat Diet Alters Gut Microbiota of Offspring and Exacerbates DSS-Induced Colitis in Adulthood.

Authors:  Runxiang Xie; Yue Sun; Jingyi Wu; Shumin Huang; Ge Jin; Zixuan Guo; Yujie Zhang; Tianyu Liu; Xiang Liu; Xiaocang Cao; Bangmao Wang; Hailong Cao
Journal:  Front Immunol       Date:  2018-11-13       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.